Waterless alternative to laboratory baths
Bead Bath delivers temperature uniformity while eliminating water
The San Antonio, Texas-based firm says the waterless Bead Bath delivers exceptional temperature uniformity while eliminating water, which can be a major source of contamination in laboratories.
The Bead Bath is always on, ready for the next experiment, so scientists do not have to plan around warm-up times. There is also no risk of burn out because there is no water to evaporate. The Bead Bath also keeps samples organised, naturally holding vessels in place without the need for racks, floats and bottleneck weights.
In addition to watertight containers, scientists can safely incubate multi-well plates, petri dishes, and open-top samples at any angle.
The Bead Bath also requires little maintenance.
Lab Armor Beads can be used to replace water in existing water baths, aluminum blocks in dry baths and even ice in ice buckets. These beads can also be used in containers placed in ovens and incubators to replace sample racks.
The Lab Armor Bead Bath’s thermal uniformity is: 37°C ±0.5°C and 65°C ±1.0°C with a temperature range of 5°C above ambient to 80°C. They support a temperature range of –100°C to +400°C in laboratory equipment.
You may also like
Trending Articles
You may also like
Manufacturing
BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech
The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing
Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform
The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing
Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market
Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Manufacturing
FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing
A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain